Citation Impact
Citing Papers
Three-Gene Prognostic Classifier for Early-Stage Non–Small-Cell Lung Cancer
2007
Homeostatic maintenance of natural Foxp3 + CD25+ CD4+ regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization
2005 StandoutNobel
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations
2013 Standout
Gender Disparity in Liver Cancer Due to Sex Differences in MyD88-Dependent IL-6 Production
2007 StandoutScience
Stability of person-specific blood-based infrared molecular fingerprints opens up prospects for health monitoring
2021 StandoutNobel
Hallmarks of Cancer: The Next Generation
2011 Standout
Prognostic role of vascular endothelial growth factor in hepatocellular carcinoma: systematic review and meta-analysis
2009
Systematic review, including meta-analyses, on the management of locally advanced pancreatic cancer using radiation/combined modality therapy
2007
The RNA Binding Protein Quaking Regulates Formation of circRNAs
2015 Standout
Cancer Invasion and the Microenvironment: Plasticity and Reciprocity
2011 Standout
Cancer Evolution and the Limits of Predictability in Precision Cancer Medicine
2016
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
A view on drug resistance in cancer
2019 StandoutNature
Oncogenic roles of EMT-inducing transcription factors
2014
Ferroptosis as a p53-mediated activity during tumour suppression
2015 StandoutNature
Epithelial-Mesenchymal Transitions in Development and Disease
2009 Standout
Sex Hormone Dependency of Diethylnitrosamine‐induced Liver Tumors in Mice and Chemoprevention by Leuprorelin
2001
Molecular mechanisms of epithelial–mesenchymal transition
2014 Standout
The biology and management of non-small cell lung cancer
2018 StandoutNature
TREM and TREM-like receptors in inflammation and disease
2009 Standout
First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer
2014 Standout
Plasticity of tumour and immune cells: a source of heterogeneity and a cause for therapy resistance?
2013
Strategies for discovering novel cancer biomarkers through utilization of emerging technologies
2008
Lung Cancer
2008 Standout
Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future
2017 Standout
HIF2α cooperates with RAS to promote lung tumorigenesis in mice
2009 StandoutNobel
Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications
2022 Standout
Improving de novo protein binder design with deep learning
2023 StandoutNobel
MDM2 and MDMX promote ferroptosis by PPARα-mediated lipid remodeling
2020
Osimertinib or Platinum–Pemetrexed in EGFR T790M–Positive Lung Cancer
2016 Standout
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
Antibody-based proteomics: fast-tracking molecular diagnostics in oncology
2010
DNp73 Exerts Function in Metastasis Initiation by Disconnecting the Inhibitory Role of EPLIN on IGF1R-AKT/STAT3 Signaling
2013
New plays in the p53 theater
2010
TREM2 Lipid Sensing Sustains the Microglial Response in an Alzheimer’s Disease Model
2015 Standout
miR-34 and SNAIL form a double-negative feedback loop to regulate epithelial-mesenchymal transitions
2011
Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self
2005 StandoutNobel
Hypoxia and the extracellular matrix: drivers of tumour metastasis
2014 StandoutNobel
DNA methylation at promoter regions of interleukin 1B, interleukin 6, and interleukin 8 in non-small cell lung cancer
2012
Impeding Macrophage Entry into Hypoxic Tumor Areas by Sema3A/Nrp1 Signaling Blockade Inhibits Angiogenesis and Restores Antitumor Immunity
2013
SciClone: Inferring Clonal Architecture and Tracking the Spatial and Temporal Patterns of Tumor Evolution
2014
New Insights into the Regulation of Epithelial–Mesenchymal Transition and Tissue Fibrosis
2012
Prognostic Role of Twist, Slug, and Foxc2 Expression in Stage I Non–Small-Cell Lung Cancer After Curative Resection
2011
Emerging Biological Principles of Metastasis
2017 Standout
A role for Rho GTPases and cell–cell adhesion in single-cell motility in vivo
2009
Regulatory T cells in transplantation tolerance
2003 StandoutNobel
EMT: 2016
2016 Standout
The causes and consequences of genetic heterogeneity in cancer evolution
2013 StandoutNature
MiR-1 and miR-200 inhibit EMT via Slug-dependent and tumorigenesis via Slug-independent mechanisms
2012
Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks
2020 StandoutNobel
Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer
2017 Standout
F-box proteins: Keeping the epithelial-to-mesenchymal transition (EMT) in check
2015
EMT-activating transcription factors in cancer: beyond EMT and tumor invasiveness
2012
Pancreatic Cancer
2010 Standout
Basic and Therapeutic Aspects of Angiogenesis
2011 Standout
The PI3K Pathway in Human Disease
2017 Standout
Metastatic colonization by circulating tumour cells
2016 StandoutNature
Hepatocellular Carcinoma
2011 Standout
Regulatory networks defining EMT during cancer initiation and progression
2013 Standout
A UTX-MLL4-p300 Transcriptional Regulatory Network Coordinately Shapes Active Enhancer Landscapes for Eliciting Transcription
2017
AZD9291 in EGFR Inhibitor–Resistant Non–Small-Cell Lung Cancer
2015 Standout
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
2016 Standout
Naturally Arising CD4+Regulatory T Cells for Immunologic Self -Tolerance and Negative Control of Immune Responses
2003 StandoutNobel
Prevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria Blocked
1997 StandoutScience
Neuropilin 1 deficiency on CD4+Foxp3+ regulatory T cells impairs mouse melanoma growth
2012 StandoutNobel
Intratumor Heterogeneity: Seeing the Wood for the Trees
2012
Epithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosis
2015 StandoutNobel
A Perspective on Cancer Cell Metastasis
2011 StandoutScience
Targeting ALK: Precision Medicine Takes on Drug Resistance
2017
Cancer: Evolution Within a Lifetime
2014
DAMP-sensing receptors in sterile inflammation and inflammatory diseases
2019 Standout
Direct Expansion of Functional CD25+ CD4+ Regulatory T Cells by Antigen-processing Dendritic Cells
2003 StandoutNobel
Treatment of Disseminated Germ-Cell Tumors with Cisplatin, Bleomycin, and either Vinblastine or Etoposide
1987 Standout
The Ins and Outs of the Epithelial to Mesenchymal Transition in Health and Disease
2011
Mechanisms of Vessel Branching
2009
Tumor Suppression by LKB1: SIK-ness Prevents Metastasis
2009
Interleukin 2 Signaling Is Required for CD4+ Regulatory T Cell Function
2002
Intratumor Heterogeneity: Evolution through Space and Time
2012
Definition of target antigens for naturally occurring CD4+ CD25+ regulatory T cells
2005 StandoutNobel
A p53/miRNA-34 axis regulates Snail1-dependent cancer cell epithelial–mesenchymal transition
2011
Immune Regulation of Cancer
2010
BRCA1-IRIS promotes human tumor progression through PTEN blockade and HIF-1α activation
2018 StandoutNobel
Etoposide (VP-16–213)
1985
Epithelial Plasticity: A Common Theme in Embryonic and Cancer Cells
2013 StandoutScience
Neuropilin-1 is a receptor for transforming growth factor β-1, activates its latent form, and promotes regulatory T cell activity
2008
Parallel evolution of tumour subclones mimics diversity between tumours
2013
Canonical Wnt signaling regulates Slug activity and links epithelial–mesenchymal transition with epigenetic Breast Cancer 1, Early Onset (BRCA1) repression
2012
Works of Wing‐Kai Chan being referenced
Pretreatment Epidermal Growth Factor Receptor ( EGFR ) T790M Mutation Predicts Shorter EGFR Tyrosine Kinase Inhibitor Response Duration in Patients With Non–Small-Cell Lung Cancer
2012
Targeting Neuropilin 1 as an Antitumor Strategy in Lung Cancer
2007
Concurrent chemoradiotherapy treatment of locally advanced pancreatic cancer: Gemcitabine versus 5-fluorouracil, a randomized controlled study
2003
p53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug
2009
A Five-Gene Signature and Clinical Outcome in Non–Small-Cell Lung Cancer
2007
TREM-1 Expression in Tumor-associated Macrophages and Clinical Outcome in Lung Cancer
2007
Prognostic Significance of Vascular Endothelial Growth Factor, Basic Fibroblast Growth Factor, and Angiogenin in Patients With Resectable Hepatocellular Carcinoma After Surgery
2003
Phase II study of flutamide in the treatment of hepatocellular carcinoma
1996
Phase II Trial of Systemic Recombinant Interleukin-2 in the Treatment of Refractory Nasopharyngeal Carcinoma
2001
Alternating non-cross-resistant combination chemotherapy for small cell anaplastic carcinoma of the lung
1982